MRI Interventions Fresh Insights

It's been a while since we wrote about MRI Interventions (MRIC). We want to share with you two pieces that will enhance your understanding of its potential. 

Kris Tuttle at SoundView Technology Group has updated his research piece on MRIC, and the entire work is exceptional. You can find the presentation below. 

Last week, Voyager Therapeutics (VYGR) posted its April 2018 Corporate presentation to its site. The presentation, which is included at the bottom of this post, highlights the importance of MRIC's ClearPoint system for the delivery of the Voyager Parkinson Payload to the brain. Slides 25-52 contain commentaries on the phase one trial and the posterior approach to delivery. In addition, on page 97, VYGR discusses its goal "to deliver a one-time administration of a 'vectored' monoclonal antibody directed against Tau to potentially treat primary and secondary tauopathies including Alzheimer's disease". 

To think that the MRIC ClearPoint system might be the delivery method for some of the therapeutics developed as part of the VYGR-AbbVie collaboration is really exciting.

MRIC will be presenting at the MicroCap Conference being held in New York City on April 9th and 10th. The conference is free for qualified investors. You can find more at https://microcapconf.com/.

Of interest: 100 to 1 - MRI Interventions, Inc.

Enjoy! 

Michael Bigger. Follow me on Twitter and StockTwits.

MRI Interventions SoundView Note Published Mar 2018 by Research2Zero on Scribd

Voyager Corporate Presentation April 2018 by biggercapital on Scribd